CHEMM — ChemoMetec A/S Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual income statement for ChemoMetec A/S, fiscal year end - June 30th, DKK millions except per share, conversion factor applied.

	2021 June 30th	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	DAS	DAS	DAS	DAS	DAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	281	428	444	408	496
Cost of Revenue
Gross Profit	230	343	351	321	412
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	165	226	214	239	259
Operating Profit	116	203	231	169	237
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	113	203	230	177	240
Provision for Income Taxes
Net Income After Taxes	88.4	159	179	136	186
Net Income Before Extraordinary Items
Net Income	88.4	159	179	136	186
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	88.4	159	179	136	186
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	5.17	9.16	10.3	7.83	12.2
Dividends per Share